Ian Ranger: The role of group risk amid mounting pressure on the NHS

With 6.8 million people now on the waiting list for treatment in England, the NHS has a huge mountain to climb. As these pressures continue to mount, and the number of people struggling to access treatment continues to grow, the insurance industry and employers are looking at how the treatment gap can be bridged. As a result, group risk products have come to the fore. Understanding the value First and foremost, employer and employee understanding of the value group protection products can provide has never been better as the pandemic alerted people to the importance of health and w...